InvestorsHub Logo
Followers 79
Posts 24429
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 09/17/2018 8:36:22 AM

Monday, September 17, 2018 8:36:22 AM

Post# of 27331
CLRB - 2.19 Pre-market now at 2.70/2.85

FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.